We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGMK
11901
CALL
DELISTED
LogicMark
LGMK
$25K ﹤0.01%
67
-95
-59% -$53.4K
MFG icon
11902
CALL
Mizuho Financial
MFG
$132B
$25K ﹤0.01%
+11,500
New +$26.7K
KG
11903
CALL
Kestrel Group
KG
$61.7M
$25K ﹤0.01%
585
-2,110
-78% -$89.7K
OPFI icon
11904
CALL
OppFi
OPFI
$610M
$25K ﹤0.01%
+10,900
New +$31.1K
PHUN icon
11905
Phunware
PHUN
$42.8M
$25K ﹤0.01%
417
-250
-37% -$17.9K
TISI icon
11906
Team
TISI
$101M
$25K ﹤0.01%
2,370
-8,741
-79% -$93.6K
XPON icon
11907
Expion360
XPON
$3.47M
$25K ﹤0.01%
+11
New +$37.9K
ZH
11908
PUT
Zhihu
ZH
$273M
$25K ﹤0.01%
3,967
-883
-18% -$7.13K
ENZ
11909
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
$25K ﹤0.01%
+11,400
New +$27.5K
RNLX
11910
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$25K ﹤0.01%
19,800
+8,200
+71% +$17.9K
NVOS
11911
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$25K ﹤0.01%
+2,338
New +$38K
MBSC.WS
11912
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$25K ﹤0.01%
417,182
-800
-0.2% -$92
IDEX
11913
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$25K ﹤0.01%
722
+401
+125% +$30.4K
MTL.PR
11914
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$25K ﹤0.01%
58,229
ADAP
11915
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$24K ﹤0.01%
22,100
-36,500
-62% -$67.1K
AKBA icon
11916
CALL
Akebia Therapeutics
AKBA
$242M
$24K ﹤0.01%
75,100
-81,100
-52% -$31.8K
BRFS
11917
CALL
DELISTED
BRF SA
BRFS
$24K ﹤0.01%
+10,100
New +$29.9K
CLIR icon
11918
ClearSign Technologies
CLIR
$31.7M
$24K ﹤0.01%
+2,570
New +$27.4K
CRBP icon
11919
CALL
Corbus Pharmaceuticals
CRBP
$195M
$24K ﹤0.01%
4,810
+180
+4% +$1.27K
HYPD
11920
Hyperion DeFi Inc
HYPD
$41.2M
$24K ﹤0.01%
+155
New +$22.9K
GOCO
11921
PUT
DELISTED
GoHealth
GOCO
$24K ﹤0.01%
4,480
-693
-13% -$5.22K
HEPA
11922
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$24K ﹤0.01%
48
+3
+7% +$1.83K
IMMP
11923
PUT
Immutep
IMMP
$56M
$24K ﹤0.01%
15,400
-4,300
-22% -$8.74K
INDP icon
11924
Indaptus Therapeutics
INDP
$143M
$24K ﹤0.01%
+389
New +$30.3K
KZIA
11925
CALL
Kazia Therapeutics
KZIA
$154M
$24K ﹤0.01%
430
-844
-66% -$94.4K

Similar funds

Citadel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
  • Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.